Approximately 1.5 million Americans live with lupus, with women accounting for 9 out of 10 cases. Lupus can be challenging to diagnose due to its varied symptoms and individualized immune system effects. Treatment can also be difficult, with drugs carrying potential side effects. Many individuals with lupus may not even realize they have it. Researchers are actively studying lupus through clinical trials to develop new treatments.
HealthyWomen recently interviewed Dr. Anca Askanase, founder and clinical director of Columbia’s Lupus Center, on the value of clinical trials for lupus. Clinical trials assess the safety and effectiveness of medications before FDA approval. They occur in phases, with Phase 3 being crucial for FDA approval. Various types of lupus clinical trials exist, offering hope for new and improved treatments.
Patient participation in clinical trials provides benefits, such as early access to potentially effective medications. Resources like the Lupus Foundation of America can help individuals find clinical trials. While entering a clinical trial may be intimidating, discussing the pros and cons with a healthcare provider and hearing from others who have participated can provide valuable insights. Clinical trials play a vital role in advancing research for diseases like lupus by creating new therapeutic options.
